(Q48090684)

8 February 2018

title

Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy (English)

1 reference

8 February 2018

0 references

2

1 reference

8 February 2018

Cassandra Szoeke

5

1 reference

8 February 2018

Mark J. Cook

6

1 reference

8 February 2018

Trevor Kilpatrick

8

1 reference

8 February 2018

author name string

Taylor I

1

1 reference

8 February 2018

Litewka L

3

1 reference

8 February 2018

MacGregor LR

4

1 reference

8 February 2018

Mitchell P

7

1 reference

8 February 2018

Tubridy N

9

1 reference

8 February 2018

publication date

1 February 2004

1 reference

8 February 2018

Journal of Clinical Neuroscience

published in

1 reference

8 February 2018

volume

11

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

153-158

1 reference

8 February 2018

Remyelination in multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Thalamic neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Optimizing the association between disability and biological markers in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Thalamic and caudate volumes in monozygotic twins discordantfor schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2803%2900145-0

7 January 2021

10.1016/S0967-5868(03)00145-0

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7vj6rbcad5b5zgqtxdrnsfaxza

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_7vj6rbcad5b5zgqtxdrnsfaxza

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7vj6rbcad5b5zgqtxdrnsfaxza

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/7vj6rbcad5b5zgqtxdrnsfaxza

1 reference

30 July 2022